Click it and Unblock the Notifications
Latest Updates
-
Women, Menopause And Bone Health: Doctor Explains Why Osteoporosis Risk Rises After 40 -
Can Breast Cancer Be Detected Before Symptoms Appear? A Doctor Explains The Role Of Screening -
Papankusha Ekadashi 2026: October 21 Or 22? Know The Correct Date, Tithi And Significance -
OTT Releases This Week (October 19–25): New Movies And Series On Netflix, Prime Video, JioHotstar And Zee5 -
Police Commemoration Day 2026: Know The History, Significance And Programmes Planned Across India This Year -
Deepika Padukone And Ranveer Singh Announce Second Daughter’s Name On Dussehra, Share Family Photo -
Who Was Karthik Sabesh? Tamil Actor Passes Away At 37, Days After Uncle And Composer Deva’s Death -
Who Is Ravleen Varghese? Meet The First Malayali Model To Walk The Victoria’s Secret Runway -
World Osteoporosis Day 2026: A Minor Fall, A Major Fracture — Doctor On Why Older Adults Should Be Careful -
Durga Visarjan 2026: October 20 or 21? Know Shubh Muhurat, Rituals And Significance
Antibody-Based Test May Differentiate Zika From Other Infections
Scientists have developed a new antibody-based test that can help differentiate Zika virus infections from infections caused by similar viruses such as dengue and West Nile.
Scientists have developed a new antibody-based test that can help differentiate Zika virus infections from infections caused by similar viruses such as dengue and West Nile.
Zika is a mosquito-borne disease and is linked to severe congenital birth defects.
The new antibody-based test, developed by researchers at the University of California - Berkeley and biotechnology company Humabs BioMed, has very high sensitivity (91.8 per cent) and specificity (95.9 per cent) for identifying Zika virus infections.
"The whole world has been in urgent need of a serological method to distinguish dengue virus from Zika virus infections, and this (is) the first to have such high sensitivity and specificity in dengue-endemic regions," said Eva Harris, Professor at UC-B.
To develop the test, Humabs generated a new human antibody to the Zika virus.
The researchers then implemented the test on samples from Zika patients, with or without prior exposure to dengue virus, and samples from dengue patients infected either once or more than once with different types of the dengue virus.
The data, published in the journal Proceedings of the National Academy of Sciences, showed that the test was highly sensitive, specific and robust.
"These results support that the antibody-based assay that we have developed is highly effective in detecting both recent and past Zika virus infections and in discriminating Zika from other flavivirus infections," said Davide Corti, senior Vice President and Chief Scientific Officer from Humabs BioMed.
"This novel test has the potential to become an effective, simple and low-cost solution for Zika surveillance programs, prevalence studies and clinical intervention trials in flavivirus-endemic areas," Corti added.
Inputs From IANS
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.
Continue with Google
